WEKO3
アイテム
{"_buckets": {"deposit": "d613f2b4-d8aa-4c12-9b42-96af5a9f648c"}, "_deposit": {"created_by": 11, "id": "3606", "owners": [11], "pid": {"revision_id": 0, "type": "depid", "value": "3606"}, "status": "published"}, "_oai": {"id": "oai:shiga-med.repo.nii.ac.jp:00003606", "sets": ["79"]}, "author_link": ["675"], "item_4_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2020-05-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "5", "bibliographicPageEnd": "666", "bibliographicPageStart": "663", "bibliographicVolumeNumber": "140", "bibliographic_titles": [{}, {"bibliographic_title": "YAKUGAKU ZASSHI", "bibliographic_titleLang": "en"}]}]}, "item_4_creator_3": {"attribute_name": "著者別名", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "TERADA, Tomohiro"}], "nameIdentifiers": [{"nameIdentifier": "675", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "10324641", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=10324641"}]}]}, "item_4_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The development of cancer genomic medicine has been embraced as an important new policy issue in “The 3rd Basic Plan to Promote Cancer Control Programs” formulated by the Japanese government. Cancer-associated gene panel testing has been recognized by the public health insurance system since July 2019, and is a critical component of the clinical implementation of genomic science. Because of this dynamic change in cancer medicine, pharmacists are now expected to acquire knowledge about genomic science, and to apply it to individualized and appropriate pharmacotherapies. This review outlines the roles of pharmacists in cancer genomic medicine.", "subitem_description_type": "Abstract"}]}, "item_4_description_42": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"subitem_description": "Journal Article", "subitem_description_type": "Other"}]}, "item_4_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "公益社団法人 日本薬学会"}]}, "item_4_relation_10": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "32378668", "subitem_relation_type_select": "PMID"}}]}, "item_4_relation_11": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1248/yakushi.19-00217-3"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1248/yakushi.19-00217-3", "subitem_relation_type_select": "DOI"}}]}, "item_4_rights_12": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "©2020 The Pharmaceutical Society of Japan"}]}, "item_4_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0031-6903", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "寺田, 智祐"}], "nameIdentifiers": [{"nameIdentifier": "675", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "10324641", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=10324641"}]}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "genomic science", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cancer genomic medicine", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "pharmacist", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "がんゲノム医療における薬剤師の役割", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "がんゲノム医療における薬剤師の役割"}, {"subitem_title": "Roles of pharmacists in cancer genomic medicine.", "subitem_title_language": "en"}]}, "item_type_id": "4", "owner": "11", "path": ["79"], "permalink_uri": "http://hdl.handle.net/10422/00012724", "pubdate": {"attribute_name": "公開日", "attribute_value": "2020-06-19"}, "publish_date": "2020-06-19", "publish_status": "0", "recid": "3606", "relation": {}, "relation_version_is_last": true, "title": ["がんゲノム医療における薬剤師の役割"], "weko_shared_id": -1}
がんゲノム医療における薬剤師の役割
http://hdl.handle.net/10422/00012724
http://hdl.handle.net/10422/0001272484672d66-dea7-4174-908d-f15723ae977b
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2020-06-19 | |||||
タイトル | ||||||
タイトル | がんゲノム医療における薬剤師の役割 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | Roles of pharmacists in cancer genomic medicine. | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | genomic science | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | cancer genomic medicine | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | pharmacist | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
寺田, 智祐
× 寺田, 智祐 |
|||||
著者別名 |
TERADA, Tomohiro
× TERADA, Tomohiro |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The development of cancer genomic medicine has been embraced as an important new policy issue in “The 3rd Basic Plan to Promote Cancer Control Programs” formulated by the Japanese government. Cancer-associated gene panel testing has been recognized by the public health insurance system since July 2019, and is a critical component of the clinical implementation of genomic science. Because of this dynamic change in cancer medicine, pharmacists are now expected to acquire knowledge about genomic science, and to apply it to individualized and appropriate pharmacotherapies. This review outlines the roles of pharmacists in cancer genomic medicine. | |||||
書誌情報 |
en : YAKUGAKU ZASSHI 巻 140, 号 5, p. 663-666, 発行日 2020-05-01 |
|||||
出版者 | ||||||
出版者 | 公益社団法人 日本薬学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0031-6903 | |||||
PMID | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 32378668 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1248/yakushi.19-00217-3 | |||||
関連名称 | 10.1248/yakushi.19-00217-3 | |||||
権利 | ||||||
権利情報 | ©2020 The Pharmaceutical Society of Japan | |||||
資源タイプ | ||||||
内容記述タイプ | Other | |||||
内容記述 | Journal Article |